BioCentury
ARTICLE | Company News

Management tracks: AbbVie, Adverum

October 19, 2018 10:35 PM UTC

AbbVie Inc. (NYSE:ABBV) said EVP and CFO William Chase will retire in mid-2019. Effective immediately, Chase becomes EVP of finance and administration until his retirement and VP and Controller Robert Michael will succeed Chase as SVP and CFO. Brian Durkin, VP of internal audit, will replace Michael.

Adverum Biotechnologies Inc. (NASDAQ:ADVM) promoted CFO Leone Patterson to president and CEO. Patterson has served as interim president and CEO of the gene therapy company since former President and CEO Amber Salzman left in May. Spokesperson Katherine Bock said Patterson will continue as CFO until Adverum hires a successor. Patterson will also join Adverum's board...